Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Consequently, the PP analysis included 58 subjects (Fig. 1).Baseline characteristics and demographics at screening or baseline visitsParametergeniVida™ bone blend n = 31Placebo n = 33All + n = 64Age (years)54.8 ± 2.554.7 ± 2.354.7 ± 2.4Body weight (kg)68.0 ± 9.271.1 ± 9.069.6 ± 9.2BMI (kg/m2)24.9 ± 2.825.9 ± 2.825.4 ± 2.9Fat mass (%)a 38.0 ± 6.036.8 ± 6.137.5 ± 6.1Years since menopause (Y)2.2 ± 0.8 (n = 30)2.1 ± 0.8 (n = 32)2.1 ± 0.8 (n = 62)Hot flashes24/3127/3351/64Hot flashes since (Y)5.4 ± 5.8 (n = 24)8.1 ± 10.3 (n = 27)6.8 ± 8.5 (n = 51)T-score (lumbar spine)−0.58 ± 1.06−0.48 ± 1.33−0.53 ± 1.20T-score (hip)−0.52 ± 0.86−0.53 ± 0.84−0.52 ± 0.84Previous fractures more than 1 year before inclusion0/310/330/64Intake of concomitant medication24/3126/3350/64Intake of multivitaminsb 15/3114/3329/64Smokers1/31 (max 10 cigarettes/day)0/331/64Systolic BP (mmHg)114 ± 13115 ± 11114 ± 12Diastolic BP (mmHg)72 ± 973 ± 873 ± 9Heart rate (bpm)68 ± 767 ± 867 ± 7Total cholesterol(mg/mL)223.0 ± 35.4*205.5 ± 29.0214.0 ± 33.2Estradiol (pg/mL)10.2 ± 2.110.4 ± 3.310.3 ± 2.8Follicle-stimulating hormone (mIU/mL)109.9 ± 47.4104.8 ± 33.7107.3 ± 40.7 aat visit 1 (baseline); + data only include subjects who completed the study bAbout 25% of the subjects reported taking them regularly (~200 IU vitamin D and 150 to 300 mg Ca)* p < 0.5 compared to placeboReference ranges: Total cholesterol: <200 mg/mL
Source: Data set, subjects demographics and screening characteristics. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Study design awaiting verification.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.
Meta-analysis unclear · Double-blind reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study
Source: Article title.
In this randomized, double-blind, placebo-controlled, 6-month pilot intervention study, the effect of a combination of genistein (30 mg/days), vitamin D3 (800 IU/days), vitamin K1 (150 μg/days) and polyunsaturated fatty acids 1 g (PUFAs) as ethyl ester: EPA/DHA ratio = ~2/1) on bone health in postmenopausal women was investigated.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study
Study design awaiting verification · European Journal of Nutrition · 2012
Original publication title
Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study
© The Author(s) 2012
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
Many postmenopausal women desire non-pharmaceutical alternatives to hormone therapy for protection against osteoporosis. Soybean isoflavones, especially genistein, are being studied for this purpose. This study examined the effects of synthetic genistein in combination with other potential bone-protective dietary molecules on bone mineral density (BMD) in early postmenopausal women.
Source: PurposeAbstract: What methods does the paper describe?
In this 6-month double-blind pilot study, 70 subjects were randomized to receive daily either calcium only or the geniVida™ bone blend (GBB), which consisted of genistein (30 mg/days), vitamin D3 (800 IU/days), vitamin K1 (150 μg/days) and polyunsaturated fatty acids (1 g polyunsaturated fatty acids as ethyl ester: eicosapentaenoic acid/docosahexaenoic acid ratio = ~2/1). Markers of bone resorption and formation and BMD at the femoral neck, lumbar spine, Ward’s triangle, trochanter and intertrochanter, total hip and whole body were assessed.
Source: MethodsAbstract: Results
Subjects supplemented with the GBB (n = 30) maintained femoral neck BMD, whereas in the placebo group (n = 28), BMD significantly decreased (p = 0.007). There was also a significant difference (p < 0.05) in BMD between the groups at Ward’s triangle in favor of the GBB group. Bone-specific alkaline phosphatase and N-telopeptide significantly increased in the GBB group in comparison with those in baseline and in the placebo group. The GBB was well tolerated, and there were no significant differences in adverse events between groups.
Source: ResultsAbstract: Conclusions
The GBB may help to prevent osteoporosis and reduce fracture risk, at least at the hip, in postmenopausal women. Larger and longer-term clinical trials are warranted.
Source: ConclusionsAuthors’ abstract
Purpose
Many postmenopausal women desire non-pharmaceutical alternatives to hormone therapy for protection against osteoporosis. Soybean isoflavones, especially genistein, are being studied for this purpose. This study examined the effects of synthetic genistein in combination with other potential bone-protective dietary molecules on bone mineral density (BMD) in early postmenopausal women.
Methods
In this 6-month double-blind pilot study, 70 subjects were randomized to receive daily either calcium only or the geniVida™ bone blend (GBB), which consisted of genistein (30 mg/days), vitamin D3 (800 IU/days), vitamin K1 (150 μg/days) and polyunsaturated fatty acids (1 g polyunsaturated fatty acids as ethyl ester: eicosapentaenoic acid/docosahexaenoic acid ratio = ~2/1). Markers of bone resorption and formation and BMD at the femoral neck, lumbar spine, Ward’s triangle, trochanter and intertrochanter, total hip and whole body were assessed.
Results
Subjects supplemented with the GBB (n = 30) maintained femoral neck BMD, whereas in the placebo group (n = 28), BMD significantly decreased (p = 0.007). There was also a significant difference (p < 0.05) in BMD between the groups at Ward’s triangle in favor of the GBB group. Bone-specific alkaline phosphatase and N-telopeptide significantly increased in the GBB group in comparison with those in baseline and in the placebo group. The GBB was well tolerated, and there were no significant differences in adverse events between groups.
Conclusions
The GBB may help to prevent osteoporosis and reduce fracture risk, at least at the hip, in postmenopausal women. Larger and longer-term clinical trials are warranted.
Publication and source details
Original title: Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study
Joan Lappe; Iris Kunz; Igor Bendik; Kevin Prudence; Peter Weber; Robert Recker; Robert P. Heaney
European Journal of Nutrition · 2012
© The Author(s) 2012https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T13:22:04.263880+00:00
DOI: 10.1007/s00394-012-0304-x · PMC3549413